2
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
6
Brain Neoplasms
3
Neoplasms
2
Lung Neoplasms
2
Thrombophilia
1
Stomatitis
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Periodontitis
1
Patient Satisfaction
1
Neoplasms, Plasma Cell
1
Motor Activity
1
Liver Neoplasms
1
Liver Diseases
1
Head and Neck Neoplasms
1
Glioblastoma
1
Gastrointestinal Stromal Tumors
1
Febrile Neutropenia
1
EGFR-Mutant Lung Cancer
1
Deglutition Disorders
1
Communication Disorders
1
Colorectal Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Pancreatic Ductal
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma
1
Breast Diseases
1
Blood Coagulation Disorders
1
Advanced Breast Cancer
1
Interventions
Anastrozole
8
exemestane
7
Trastuzumab
7
Letrozole
7
palbociclib
6
Docetaxel
6
abemaciclib
5
Fulvestrant
5
ribociclib
4
pyrotinib
4
entinostat
4
Cyclophosphamide
4
Tamoxifen
3
Doxorubicin
3
pertuzumab
2
Sodium Chloride
2
Paclitaxel
2
Lapatinib
2
Gonadotropin-Releasing Hormone
2
Exercise
2
Everolimus
2
Epirubicin
2
Drug Evaluation
2
Capecitabine
2
Botulinum Toxins, Type A
2
Blood Specimen Collection
2
Aromatase Inhibitors
2
AZD9833
2
tucatinib
1
trastuzumab deruxtecan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breast Diseases
×
Lead
×
Clear all
NCT04842240
2021-04-13
PROM-Q
The Leeds Teaching Hospitals NHS Trust
Unknown
60 enrolled